Catalyst Wire Dossier Catalyst Wire Dossier

ASLAN002

· ASLAN Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASLAN002, covering 2017-01-25 to 2017-01-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Multiple Ascending Dose Study of ASLAN002 in Subjects With Advanced or Metastatic Solid Tumours [Phase 1]

See pricing